United States Antimony (NYSE:UAMY) Given New $6.50 Price Target at HC Wainwright

United States Antimony (NYSE:UAMY) had its price objective trimmed by HC Wainwright from $9.25 to $6.50 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other research analysts also recently weighed in on UAMY. Weiss Ratings reiterated a “sell (d-)” rating on shares of United States Antimony in a research note on Monday, September 14th. Texas Capital upgraded United States Antimony to a “strong-buy” rating in a research note on Wednesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, United States Antimony has an average rating of “Moderate Buy” and an average price target of $8.75.

United States Antimony Trading Up 7.3%

Shares of NYSE UAMY traded up $0.21 during midday trading on Friday, reaching $3.12. 6,725,830 shares of the company were exchanged, compared to its average volume of 5,961,503. United States Antimony has a 1 year low of $2.53 and a 1 year high of $12.64. The stock has a fifty day simple moving average of $3.77 and a 200 day simple moving average of $6.89. The stock has a market cap of $467.27 million, a P/E ratio of -20.81 and a beta of 0.49.

United States Antimony (NYSE:UAMY) last issued its quarterly earnings results on Thursday, November 12th. The company reported ($0.06) earnings per share (EPS) for the quarter. The company had revenue of $10.13 million during the quarter. United States Antimony had a negative net margin of 55.44% and a negative return on equity of 7.73%. As a group, analysts forecast that United States Antimony will post -0.01 earnings per share for the current year.

Insider Buying and Selling at United States Antimony

In other United States Antimony news, EVP Lloyd EVP, Chief Mining Officer, & Director bought 20,000 shares of the company’s stock in a transaction on Tuesday, September 1st. The shares were bought at an average price of $4.63 per share, for a total transaction of $92,600.00. Following the transaction, the executive vice president owned 932,881 shares of the company’s stock, valued at approximately $4,319,239.03. This trade represents a 2.19% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary Evans bought 20,000 shares of the company’s stock in a transaction on Friday, August 28th. The shares were acquired at an average price of $4.92 per share, for a total transaction of $98,400.00. Following the transaction, the chief executive officer directly owned 2,590,028 shares in the company, valued at $12,742,937.76. This trade represents a 0.78% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have acquired 62,700 shares of company stock valued at $298,592. 5.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Marshall Wace LLP boosted its position in shares of United States Antimony by 228.0% during the 3rd quarter. Marshall Wace LLP now owns 3,954,186 shares of the company’s stock worth $16,489,000 after purchasing an additional 2,748,800 shares in the last quarter. Empowered Funds LLC acquired a new position in shares of United States Antimony during the 3rd quarter worth $123,000. Global Retirement Partners LLC increased its holdings in shares of United States Antimony by 209.7% in the 3rd quarter. Global Retirement Partners LLC now owns 58,976 shares of the company’s stock valued at $246,000 after purchasing an additional 39,936 shares in the last quarter. Fifth Third Bancorp increased its holdings in shares of United States Antimony by 23.8% in the 3rd quarter. Fifth Third Bancorp now owns 494,996 shares of the company’s stock valued at $2,064,000 after purchasing an additional 95,216 shares in the last quarter. Finally, Inscription Capital LLC acquired a new stake in shares of United States Antimony in the third quarter valued at about $47,000. Institutional investors and hedge funds own 9.49% of the company’s stock.

Trending Headlines about United States Antimony

Here are a few of the latest headlines about UAMY:

• Positive Sentiment: Third-quarter revenue rose 16% year over year, to $10.13 million, providing evidence of top-line growth. Read More.
• Neutral Sentiment: HC Wainwright kept its Buy rating but cut its price target from $9.25 to $6.50. The revised target still indicates substantial potential upside from the cited $3.12 price, but the reduction reflects a more cautious outlook. Read More.
• Negative Sentiment: UAMY reported a third-quarter loss of $0.06 per share, wider than the $0.02 loss analysts expected and the $0.04 loss a year earlier. Revenue also missed estimates, while the company’s withdrawal of guidance added uncertainty. These factors were cited in reports of an overnight share decline. Read More. · Read More.

United States Antimony Company Profile

United States Antimony Corporation mines, processes and sells antimony and related products. Its offerings include antimony oxide, antimony metal and sodium antimonate, materials used in a range of industrial applications. The company also produces zeolite through its Bear River Zeolite operations in Idaho. Zeolite products are used in applications such as water treatment, agriculture and odor control. Founded in 1968, United States Antimony has processing operations in Montana and Mexico, as well as zeolite operations in Idaho.